Head-to-head · WeighScore
ShapeIn Rx vs yourEra
By GLP-1 ScorecardUpdated
Score comparison
yourEra has the higher recorded score — 83.8/100 to 60.4/100.
yourEra grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | ShapeIn Rx | yourEra |
|---|---|---|
| WeighScore | 60.4/100 | 83.8/100 |
| Grade | C | B |
| Site position | #367 | #7 |
| Semaglutide | $199/mo (compounded) | $89/mo (new-patient offer; confirm refill terms) |
| Tirzepatide | Not disclosed | $129/mo (new-patient offer; confirm refill terms) |
| Coverage | Coverage not published | 50-state clinician network; treatment availability varies by state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #367 · C
Strengths
- One of the few telehealth providers offering compounded liraglutide as a daily alternative to weekly injections
- Semaglutide is compounded with B12, and the combination is stated plainly
- Publishes a street address and a staffed phone line with hours
- States openly that telemedicine is limited to jurisdictions where its providers are licensed, rather than claiming all 50
What to consider
- Advertises Trusted by 150k Americans and Excellent 4.8 with 150k happy customers, and neither figure is attributable to a verifiable review profile
- No state list is published, only a statement that coverage is limited and a note that partner pharmacies may operate in all 50 states
- The struck-through $199 next to $149 on the homepage reads as a discount but the two prices are different medications
- Claims No Hidden Fees and No Monthly Membership while the Terms state subscriptions automatically renew
- No compounding pharmacy is named, only US-Certified Pharmacy
Site position #7 · B
Strengths
- Public new-patient month-to-month prices; advertised same price across doses while active
- Evaluation, medication, injection supplies, dose management and shipping advertised together
- Terms name Thryv Telehealth by Lavin, P.C. and three potential dispensing pharmacies
- Free requested live visit; policy promises full refund if canceled before dispatch
What to consider
- Compounded formulations are not FDA-approved branded products
- Homepage price-continuation promise and terms allowing future refill price changes need reconciliation
- Optimum coaching, nutrition, at-home labs and wearables are coming soon, with no confirmed price or launch date
- Assessment usually asynchronous; prescription issuance triggers billing, and treatment availability varies by state
Featured provider
yourEra
yourEra scores 83.8/100 (B). Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.